‘No difference of opinion with AYUSH Ministry’: Patanjali issues statement
Patanjali claims that the AYUSH ministry has categorically agreed that “Patanjali Research Foundation has appropriately worked on Covid-19 management”.Updated: Jul 01, 2020 14:12 IST
Patanjali Ayurved Ltd., on Wednesday, issued a statement saying that all documents related to the Covid-19 clinical trial have been shared with the AYUSH Ministry and that there exists “no difference of opinions between the ministry and Patanjali.
In the statement, Patanjali said that Covid-19 patients group that received its medicines, showed 67% recovery in 3 days and 100% recovery in 7 days of treatment. “That is, all 45 patients became Covid-19 negative,” the statement read.
Patanjali claims that the ministry has categorically agreed that “Patanjali Research Foundation has appropriately worked on Covid-19 management”.
Patanjali claims that "#COVID19 patients group that received its medicines, showed 67% recovery in 3 days & 100% recovery in 7 days of treatment, that is, all 45 patients became COVID negative"; says all clinical trial documents have been shared with AYUSH Ministry. pic.twitter.com/jSMTxCwLp8— ANI (@ANI) July 1, 2020
As per the statement, Patanjali says it is allowed by the Ministry to “manufacture and distribute its Divya Coronil Tablets, Divya Swasarvati and Divya AnuTaila across India”.
The company said that it has procured the licence approval for Divya Coronil tablet and Divya Swasarivati on their “traditional reported usage”.
“Ayurvedic drug licences and control clinical trials are two different streams,” the statement read.
This comes a day after Acharya Balkrishna, the chief executive officer of Patanjali clarified that the company never claimed that its newly-tested medicines would treat Covid-19.
“We cited Coronil as ayurvedic medicine for immunity boosting, fever, cough and allergic problems,” Balkrishna said, adding, “Only results of clinical trial based curing of positive patients were claimed by us”.
Last week, Patanjali Ayurved launched a drug called “Coronil”, claiming that it had cured within a week all Covid-19 patients who took part in a trial conducted in Jaipur.
The claim triggered a row with the Union AYUSH ministry directing the firm not to sell the drug.
Uttarakhand’s Ayurveda department said the firm had only applied for a licence to manufacture an immunity booster and not a cure for coronavirus.
In reply to a notice by the Uttarakhand government, Patanjali clarified not promoting any “kit” to treat Covid-19 and only sharing the findings of the “successful trial” of a medicine on patients.